Trading Resumption

Elixxer Ltd. announces the upcoming resumption of trading following the revocation of a cease trade order. Key initiatives, including a new stock option plan, received shareholder approval at the AGM. The company has also strengthened its leadership with new CEO and CFO appointments and a refreshed Board of Directors. Strategic debt restructuring and bridge financing are in place. Elixxer is actively pursuing merger and acquisition opportunities and is involved in ongoing litigation regarding its investment in Freia Farmaceutici Srl.